Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 164

1.

Selective serotonin reuptake inhibitors potentiate the rapid antidepressant-like effects of serotonin4 receptor agonists in the rat.

Lucas G, Du J, Romeas T, Mnie-Filali O, Haddjeri N, Piñeyro G, Debonnel G.

PLoS One. 2010 Feb 16;5(2):e9253. doi: 10.1371/journal.pone.0009253.

2.

Serotonin(4) (5-HT(4)) receptor agonists are putative antidepressants with a rapid onset of action.

Lucas G, Rymar VV, Du J, Mnie-Filali O, Bisgaard C, Manta S, Lambas-Senas L, Wiborg O, Haddjeri N, Piñeyro G, Sadikot AF, Debonnel G.

Neuron. 2007 Sep 6;55(5):712-25.

3.
4.

Mechanism of action of the bimodal antidepressant vilazodone: evidence for serotonin1A-receptor-mediated auto-augmentation of extracellular serotonin output.

van Amsterdam C, Seyfried CA.

Psychopharmacology (Berl). 2014 Jun;231(12):2547-58. doi: 10.1007/s00213-013-3428-7. Epub 2014 Jan 14.

PMID:
24419272
5.

The 5-HT(1A) receptor antagonist robalzotan completely reverses citalopram-induced inhibition of serotonergic cell firing.

Arborelius L, Wallsten C, Ahlenius S, Svensson TH.

Eur J Pharmacol. 1999 Oct 8;382(2):133-8.

PMID:
10528148
6.

5-HT1A receptor antagonists increase the activity of serotonergic cells in the dorsal raphe nucleus in rats treated acutely or chronically with citalopram.

Arborelius L, Nomikos GG, Grillner P, Hertel P, Höök BB, Hacksell U, Svensson TH.

Naunyn Schmiedebergs Arch Pharmacol. 1995 Aug;352(2):157-65.

PMID:
7477438
7.

Differential involvement of 5-HT(1A) and 5-HT(1B/1D) receptors in human interferon-alpha-induced immobility in the mouse forced swimming test.

Zhang H, Wang W, Jiang Z, Shang J, Zhang L.

Arzneimittelforschung. 2010;60(3):109-15. doi: 10.1055/s-0031-1296258.

PMID:
20422941
8.

Olanzapine augments the effect of selective serotonin reuptake inhibitors by suppressing GABAergic inhibition via antagonism of 5-HT₆ receptors in the dorsal raphe nucleus.

Asaoka N, Nagayasu K, Nishitani N, Yamashiro M, Shirakawa H, Nakagawa T, Kaneko S.

Neuropharmacology. 2015 Aug;95:261-8. doi: 10.1016/j.neuropharm.2015.03.032. Epub 2015 Apr 8.

PMID:
25863120
9.

Antagonism of 5-HT(1A) receptors uncovers an excitatory effect of SSRIs on 5-HT neuronal activity, an action probably mediated by 5-HT(7) receptors.

Bosker FJ, Folgering JH, Gladkevich AV, Schmidt A, van der Hart MC, Sprouse J, den Boer JA, Westerink BH, Cremers TI.

J Neurochem. 2009 Mar;108(5):1126-35. doi: 10.1111/j.1471-4159.2008.05850.x. Epub 2009 Jan 23.

10.

The rapid recovery of 5-HT cell firing induced by the antidepressant vortioxetine involves 5-HT(3) receptor antagonism.

Bétry C, Pehrson AL, Etiévant A, Ebert B, Sánchez C, Haddjeri N.

Int J Neuropsychopharmacol. 2013 Jun;16(5):1115-27. doi: 10.1017/S1461145712001058. Epub 2012 Oct 22.

PMID:
23089374
11.
12.
13.

Relevance of dorsal raphe nucleus firing in serotonin 5-HT(2C) receptor blockade-induced augmentation of SSRIs effects.

Sotty F, Folgering JH, Brennum LT, Hogg S, Mørk A, Hertel P, Cremers TI.

Neuropharmacology. 2009 Jul;57(1):18-24. doi: 10.1016/j.neuropharm.2009.03.016. Epub 2009 Apr 17.

PMID:
19376075
14.

Altered response to the selective serotonin reuptake inhibitor escitalopram in mice heterozygous for the serotonin transporter: an electrophysiological and neurochemical study.

Guiard BP, Mansari ME, Murphy DL, Blier P.

Int J Neuropsychopharmacol. 2012 Apr;15(3):349-61. doi: 10.1017/S1461145711000484. Epub 2011 Mar 25.

PMID:
21439106
15.

Neurokinin1 antagonists potentiate antidepressant properties of serotonin reuptake inhibitors, yet blunt their anxiogenic actions: a neurochemical, electrophysiological, and behavioral characterization.

Gobert A, Brocco M, Dekeyne A, Di Cara B, Bouchez G, Lejeune F, Gannon RL, Millan MJ.

Neuropsychopharmacology. 2009 Mar;34(4):1039-56. doi: 10.1038/npp.2008.176. Epub 2008 Oct 1.

16.

Delta(9)-tetrahydrocannabinol prolongs the immobility time in the mouse forced swim test: involvement of cannabinoid CB(1) receptor and serotonergic system.

Egashira N, Matsuda T, Koushi E, Higashihara F, Mishima K, Chidori S, Hasebe N, Iwasaki K, Nishimura R, Oishi R, Fujiwara M.

Eur J Pharmacol. 2008 Jul 28;589(1-3):117-21. doi: 10.1016/j.ejphar.2008.03.046. Epub 2008 Apr 8.

PMID:
18565508
18.

5-HT(1A) agonist potential of pindolol: electrophysiologic studies in the dorsal raphe nucleus and hippocampus.

Sprouse J, Braselton J, Reynolds L.

Biol Psychiatry. 2000 Jun 15;47(12):1050-5.

PMID:
10862804
19.
20.

Effect of combined administration of 5-HT1A or 5-HT1B/1D receptor antagonists and antidepressants in the forced swimming test.

Tatarczyńska E, Kłodzińska A, Stachowicz K, Chojnacka-Wójcik E.

Eur J Pharmacol. 2004 Mar 8;487(1-3):133-42.

PMID:
15033385

Supplemental Content

Support Center